289 related articles for article (PubMed ID: 36982607)
21. Stearoyl CoA desaturase is required to produce active, lipid-modified Wnt proteins.
Rios-Esteves J; Resh MD
Cell Rep; 2013 Sep; 4(6):1072-81. PubMed ID: 24055053
[TBL] [Abstract][Full Text] [Related]
22. Hot topic: using a stearoyl-CoA desaturase transgene to alter milk fatty acid composition.
Reh WA; Maga EA; Collette NM; Moyer A; Conrad-Brink JS; Taylor SJ; DePeters EJ; Oppenheim S; Rowe JD; BonDurant RH; Anderson GB; Murray JD
J Dairy Sci; 2004 Oct; 87(10):3510-4. PubMed ID: 15377629
[TBL] [Abstract][Full Text] [Related]
23. Stearoyl-CoA desaturase activity in bovine cumulus cells protects the oocyte against saturated fatty acid stress.
Aardema H; van Tol HTA; Wubbolts RW; Brouwers JFHM; Gadella BM; Roelen BAJ
Biol Reprod; 2017 May; 96(5):982-992. PubMed ID: 28486699
[TBL] [Abstract][Full Text] [Related]
24. The fatty acid desaturation index of blood lipids, as a biomarker of hepatic stearoyl-CoA desaturase expression, is a predictive factor of breast cancer risk.
Chajès V; Joulin V; Clavel-Chapelon F
Curr Opin Lipidol; 2011 Feb; 22(1):6-10. PubMed ID: 20935562
[TBL] [Abstract][Full Text] [Related]
25. The role of stearoyl-CoA desaturase in body weight regulation.
Dobrzyn A; Ntambi JM
Trends Cardiovasc Med; 2004 Feb; 14(2):77-81. PubMed ID: 15030794
[TBL] [Abstract][Full Text] [Related]
26. Adipose tissue stearoyl-CoA desaturase 1 index is increased and linoleic acid is decreased in obesity-prone rats fed a high-fat diet.
Cedernaes J; Alsiö J; Västermark A; Risérus U; Schiöth HB
Lipids Health Dis; 2013 Jan; 12():2. PubMed ID: 23298201
[TBL] [Abstract][Full Text] [Related]
27. Biochemical and physiological function of stearoyl-CoA desaturase.
Paton CM; Ntambi JM
Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E28-37. PubMed ID: 19066317
[TBL] [Abstract][Full Text] [Related]
28. Stearoyl-CoA desaturase expression and fatty acid composition in milkfish (Chanos chanos) and grass carp (Ctenopharyngodon idella) during cold acclimation.
Hsieh SL; Kuo CM
Comp Biochem Physiol B Biochem Mol Biol; 2005 May; 141(1):95-101. PubMed ID: 15820139
[TBL] [Abstract][Full Text] [Related]
29. Stearoyl-CoA Desaturase 1 as a Therapeutic Biomarker: Focusing on Cancer Stem Cells.
Min JY; Kim DH
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240297
[TBL] [Abstract][Full Text] [Related]
30. Development of a high-throughput screening assay for stearoyl-CoA desaturase using rat liver microsomes, deuterium labeled stearoyl-CoA and mass spectrometry.
Soulard P; McLaughlin M; Stevens J; Connolly B; Coli R; Wang L; Moore J; Kuo MS; LaMarr WA; Ozbal CC; Bhat BG
Anal Chim Acta; 2008 Oct; 627(1):105-11. PubMed ID: 18790133
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of stearoyl-CoA desaturase-1 in differentiating 3T3-L1 preadipocytes upregulates elongase 6 and downregulates genes affecting triacylglycerol synthesis.
Ralston JC; Badoud F; Cattrysse B; McNicholas PD; Mutch DM
Int J Obes (Lond); 2014 Nov; 38(11):1449-56. PubMed ID: 24566853
[TBL] [Abstract][Full Text] [Related]
32. Recent advances on stearoyl-Coa desaturase regulation in fatty liver diseases.
Narce M; Bellenger J; Rialland M; Bellenger S
Curr Drug Metab; 2012 Dec; 13(10):1454-63. PubMed ID: 22978399
[TBL] [Abstract][Full Text] [Related]
33. Sequential Dynamics of Stearoyl-CoA Desaturase-1(SCD1)/Ligand Binding and Unbinding Mechanism: A Computational Study.
Petroff AB; Weir RL; Yates CR; Ng JD; Baudry J
Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680068
[TBL] [Abstract][Full Text] [Related]
34. Stearoyl-CoA desaturase 1 as a therapeutic target for cancer: a focus on hepatocellular carcinoma.
Raeisi M; Hassanbeigi L; Khalili F; Kharrati-Shishavan H; Yousefi M; Mehdizadeh A
Mol Biol Rep; 2022 Sep; 49(9):8871-8882. PubMed ID: 35906508
[TBL] [Abstract][Full Text] [Related]
35. Depletion of
Xu SS; Li Y; Wang HP; Chen WB; Wang YQ; Song ZW; Liu H; Zhong S; Sun YH
Zool Res; 2023 Jan; 44(1):63-77. PubMed ID: 36317480
[TBL] [Abstract][Full Text] [Related]
36. Monounsaturated Fatty Acids in Obesity-Related Inflammation.
Ravaut G; Légiot A; Bergeron KF; Mounier C
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396940
[TBL] [Abstract][Full Text] [Related]
37. Susceptibility of pancreatic beta cells to fatty acids is regulated by LXR/PPARalpha-dependent stearoyl-coenzyme A desaturase.
Hellemans KH; Hannaert JC; Denys B; Steffensen KR; Raemdonck C; Martens GA; Van Veldhoven PP; Gustafsson JA; Pipeleers D
PLoS One; 2009 Sep; 4(9):e7266. PubMed ID: 19787047
[TBL] [Abstract][Full Text] [Related]
38. Non-clinical Pharmacology of YTX-7739: a Clinical Stage Stearoyl-CoA Desaturase Inhibitor Being Developed for Parkinson's Disease.
Tardiff DF; Lucas M; Wrona I; Chang B; Chung CY; Le Bourdonnec B; Rhodes KJ; Scannevin RH
Mol Neurobiol; 2022 Apr; 59(4):2171-2189. PubMed ID: 35060064
[TBL] [Abstract][Full Text] [Related]
39. Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1.
Jiang G; Li Z; Liu F; Ellsworth K; Dallas-Yang Q; Wu M; Ronan J; Esau C; Murphy C; Szalkowski D; Bergeron R; Doebber T; Zhang BB
J Clin Invest; 2005 Apr; 115(4):1030-8. PubMed ID: 15761499
[TBL] [Abstract][Full Text] [Related]
40. In vitro and in vivo antitumor activities of T-3764518, a novel and orally available small molecule stearoyl-CoA desaturase 1 inhibitor.
Nishizawa S; Sumi H; Satoh Y; Yamamoto Y; Kitazawa S; Honda K; Araki H; Kakoi K; Imamura K; Sasaki M; Miyahisa I; Satomi Y; Nishigaki R; Hirayama M; Aoyama K; Maezaki H; Hara T
Eur J Pharmacol; 2017 Jul; 807():21-31. PubMed ID: 28442322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
